People with mildly reduced ejection fraction, a distinct group with unique needs, account for nearly one-quarter of HF cases.

Sex discordance isn’t an explanation for gender disparities in outcomes after cardiac surgery, new data suggest. For men, ...

The study questions whether it may be best to wait to implant a support device until arriving at a level 1 shock center.

Early right-heart stabilization seems to be translating to better QoL and faster return of function, says Robert Lookstein.

This month: dental costs and increased CVD risk, targeting fear of movement, workplace wellness programs, and more.

Lauren Eberly, Stephen Paul Juraschek, and Oluwabunmi Ogungbe discuss what they learned as researchers exploring novel ...

The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...

In line with earlier studies of the general population, the findings should encourage a thoughtful approach to calcium, ...

NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone ...

At 30 days, bleeding and pacemaker rates were lower than in TRISCEND II, but long-term outcomes are eagerly awaited.

The addition of stenting to usual care reduced symptoms and improved quality of life for patients with the condition after ...

Yet the evidence should not be overinterpreted, as conventional pacing maintains an important role, says Elena Arbelo.